"We are extremely excited about forming this important collaboration between our companies and scientists that will empower ...

SkyQuest Technology Consulting published a report, titled, Biomarkers Market - Global Opportunity Analysis and Industry Forecast, 2025-2032", valued at USD 65.36 Billion in 2024. With a projected CAGR ...

Revvity, Inc. (NYSE: RVTY), today announced the launch of pHSense™ reagents, a powerful technology designed to advance ...

Q2 2025 Earnings Call Transcript August 4, 2025 Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.15, ...

Overview of Cell Isolation MarketThe global Cell Isolation Market is valued at USD 15.6 Billion in 2024 and is projected to reach a value of USD 60.56 Billion by 2035 at a CAGR (Compound Annual Growth ...

Moderate exercise may slow brain aging, protecting cognition and brain structure, while too little or too much activity may ...

Senolytic Supplements Market to Reach $350 Million by 2025, Poised for 15% CAGR Through 2032 Driven by growing focus on healthy aging and breakthroughs in cellular senescence-targeted therapies The ...

HOXB13, a B-class homeobox transcription factor, sits at the hub of developmental gene networks yet has emerged as a ...

HOXB13, a B-class homeobox transcription factor, sits at the hub of developmental gene networks yet has emerged as a ...

HOXB13, a B-class homeobox transcription factor, sits at the hub of developmental gene networks yet has emerged as a double-edged sword in human cancer.

About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current standard chemotherapy. To better understand why some tumors resist chemoth ...

Evelyn Rampler of the Department of Analytical Chemistry at the University of Vienna discusses how her team developed a ...